Thomas E. Eissenberg, Ph.D.
Assistant Professor
Department of Psychology and Institute for Drug and Alcohol Studies
Box 980205
Richmond, Virginia 23298-0205(804) 225-4617
e-mail: teissenb@vcu.edu
Corrigall, W.A., Zack, M., Eissenberg, T., Belsito, L., and Scher, R. Topography and subjective effects of smoking in adolescent cigarette smokers. Addiction. (In press).
Buchhalter A.R., Schrinel, L., and Eissenberg, T. Withdrawal Suppressing Effects of a Novel Smoking System: Comparison with Own Brand, Not Own Brand, and Denicotinized Cigarettes. Nicotine and Tobacco Research. (In press.)
Zack, M., Belsito, L., Scher, R., Eissenberg, T., and Corrigall, W.A. (2001). Effects of abstinence and smoking on information processing in adolescent smokers. Psychopharmacolgy. 153, 249-257.
Eissenberg, T., Riggins, E.C.R. III, Harkins, S.W., and Weaver, M.F. (2000). A clinical laboratory model for direct assessment of medication-induced antihyperalgesia and subjective effects: initial validation studies. Experimental and Clinical Psychopharmacology. 8, 47-60.
Gire, J.T. and Eissenberg, T. (2000). Placebo control study of acute smokeless tobacco abstinence in young adult men. Psychology of Addictive Behaviors. 14, 356-366.
Buchhalter A.R. and Eissenberg, T. (2000). Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. Nicotine and Tobacco Research, 2, 39-43.
McCaul, M.E., Wand, G.S., Eissenberg, T., Rohde, C.A., Cheskin, L.J. (2000). Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology. 22, 480-492.Eissenberg, T., and Balster, R.L.(2000). Initial Tobacco Use Episodes in Adolescents: Current Knowledge, Future Directions. Drug and Alcohol Dependence, 59 (Suppl 1), S41-S60.
Eissenberg, T. , Adams, C., Riggins, E.C.R. III, and Likness, M. (1999). Smokers' sex and the effects of tobacco cigarettes: subject-rated and physiological measures. Nicotine and Tobacco Research. 1, 317-324.
Eissenberg, T., Stitzer, M.L., Bigelow, G.E., Buchhalter, A.R., and Walsh, S.L. (1999). Relative Potency of Levo-alpha Acetylmethadol and Methadone in Humans Under Acute Dosing Conditions. Journal of Pharmacology and Experimental Therapeutics, 289, 936-946.
Eissenberg, T. and Walsh, S.L. (1999). The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Submitted for publication.
Eissenberg, T., Stitzer, M.L., and Henningfield, J.E. (1999). Current issues in nicotine replacement. In: Helping the Hard-core Smoker: a Clinicians Guide, D.F. Seidman and L.S. Covey (Eds), Lawrence Erlbaum Associates, Mahwah, NJ. pp 137-158.
Jones, H.E., Strain, E.C., Bigelow, G.E., Walsh, S.L., Stitzer, M.L., Eissenberg, T., and Johnson, R.E. (1998). Induction onto LAAM: safety and efficacy. Archives of General Psychiatry, 55, 729-736.
Eissenberg, T., Bigelow, G.E., Strain, E.C., Walsh, S.L., Brooner, R.K., Stitzer, M.L., and Johnson, R.E. (1997). Dose related efficacy of levomethadyl acetate for treatment of opioid dependence: a randomized clinical trial. Journal of the American Medical Association, 277, 1945-1951.
Eissenberg, T., Johnson, R.E., Strain, E.C., Liebson, I.A., Bigelow, G.E., Walsh, S.L., and Stitzer, M.L. (1997) Controlled opioid withdrawal evaluation during 72-hour dose omission in buprenorphine-maintained patients. Drug and Alcohol Dependence, 45, 81-91.
Eissenberg, T. and Griffiths, R.R. (1997). Human drug discrimination and multiple chemical sensitivity: caffeine exposure as an experimental model. Environmental Health Perspectives, 105 (Suppl 2), 509-513.
Allan, L.G., Siegel, S., Kulatunga-Moruzi C., Eissenberg, T., and Chapman, C.A. (1997). Isoluminance and contingent color aftereffects. Perception and Psychophysics, 59, 1327-1334.
Allan, L.G., Siegel, S., Eissenberg, T., and Thomas S.E. (1997). More on the associative interpretation of the indirect McCollough Effect. Quarterly Journal of Experimental Psychology, 50, 332-349.
Eissenberg, T., Griffiths, R.R., and Stitzer M.L. (1996b). Mecamylamine does not precipitate withdrawal in cigarette smokers. Psychopharmacology, 127, 328-336.
Eissenberg, T., Greenwald, M.K., Johnson, R.E., Liebson, I.A., Bigelow, G.E., and Stitzer, M.L. (1996a). Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans. Journal of Pharmacology and Experimental Therapeutics, 276, 449-459.
Eissenberg, T., Allan, L.G., Siegel, S, and Petrov, N. (1995). An associative interpretation of the indirect McCollough effect. Quarterly Journal of Experimental Psychology, 48B, 262-286.
Johnson, R.E., Eissenberg, T., Stitzer, M.L., Strain, E.C., Liebson, I.A., and Bigelow, G.E. (1995b). Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing. Drug and Alcohol Dependence, 40, 27-35.
Johnson, R.E., Eissenberg, T., Stitzer, M.L., Strain, E.C., Liebson, I.A., and Bigelow, G.E. (1995a). A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence, 40, 17-25.
Siegel, S., Allan, L.G., and Eissenberg, T. (1994). Scanning and form-contingent color aftereffects. Journal of Experimental Psychology: General, 123, 91-94.
Siegel, S., Allan, L.G., and Eissenberg, T. (1992). The associative basis of contingent color aftereffects. Journal of Experimental Psychology: General, 121, 79-94.
Eissenberg, T., Allan, L.G., and Siegel, S. (1992). How indirect is the "indirect" McCollough Effect? In G. Borg and G. Neeley (Eds.), Proceedings of the 8th Annual Meeting of the International Society for Psychophysics. (pp 249-254). Stockholm: Stockholm University Press.
Tipper, S.P., Eissenberg, T. and Weaver, B. (1992). The effects of practice on mechanisms of attention. Bulletin of the Psychonomic Society, 30, 77-80.
Siegel, S., Allan, L.G., Roberts, L. and Eissenberg, T. (1990). Effect of spatial contingency on the McCollough effect. Perception and Psychophysics, 48, 307-312.
Connolly, F. and Eissenberg, T. (1990). The feedback classroom: Teaching's silent friend. Technological Horizons in Education Journal, 17, 75-77.
Rudner, L.M. and Eissenberg, T. (1989). Standard setting for teacher tests. Journal of Personnel Evaluation in Education, 3, 143-149.
Eissenberg, T. and Rudner, L.M. (1988). State testing of teachers: A summary. Journal of Teacher Education. 39, 21-22.
Gire J.T. and Eissenberg, T. Placebo Control Study of Acute Smokeless Tobacco Abstinence. Poster presentation to the Sixth Annual Meeting of the Society for Research on Nicotine and Tobacco, February 18-20, 2000.
Eissenberg, T. , Adams, C., and Riggins, E.C.R. III. Women tobacco smokers are more sensitive than men to the subjective effects but not the physiological effects of tobacco cigarette smoking. Submitted to the 61st annual scientific meeting of the College on Problems of Drug Dependence, Acapulco, Mexico, June, 1999.
Eissenberg, T. A Clinical Laboratory Model for Direct Assessment of Medication-Induced Antihyperalgesia and Subjective Effects: Initial Validation Studies. Workshop presentation to the 61st annual scientific meeting of the College on Problems of Drug Dependence, Acapulco, Mexico, June, 1999.
Buchhalter, A., and Eissenberg, T. Reduced CO boost produced in humans smoking a novel smoking system. Abstract submitted to the Fifth Annual Meeting of the Society for Research on Nicotine and Tobacco, March 5-7, 1999.
Eissenberg, T., Riggins E.C., III, and Weaver, M.F. Acute effects of mecamylamine and nicotine combinations in smokers: puff topography and subjective craving. Abstract submitted to the Fifth Annual Meeting of the Society for Research on Nicotine and Tobacco, March 5-7, 1999.
Zack, M., Belisto, L., Scher, R., Eisseberg, T., Corrigall, W.A. Smoking a cigarette reduces Stroop interference to smoking words in adolescent smokers. Poster presentation to the Fifth Annual Meeting of the Society for Research on Nicotine and Tobacco, March 5-7, 1999.
Eissenberg, T. Heroin dependence treatment research: human subjects in the clinic and the laboratory. Presented to the Addiction Research Foundation, Totonto, Ontario, Canada, October, 1998. Invited Address.
Eissenberg, T. Heroin dependence treatment research: human subjects in the clinic and the laboratory. Presented to the McMaster University Psychology Department, Hamilton, Ontario, Canada, September, 1998. Invited Address.
Eissenberg, T. LAAM and Methadone: Relative Potency and Acute Physical Dependence in Humans. Presented to the 106th annual convention of the American Psychological Association, San Francisco, CA, August, 1998. Invited Address.
Eissenberg, T., Stitzer, M.L., Bigelow, G.E., Buchhalter, A.R., and Walsh, S.L. Comparison of acute physical dependence duration in humans after single doses of LAAM or methadone. Presented to the 60th annual scientific meeting of the College on Problems of Drug Dependence, Scottsdale, AZ, June, 1998.
Eissenberg, T., Kennedy, K., Riggins, E.C. III, and Likness, M.A. (1998). PC-based concurrent measurement of puff topography and physiological and subjective effects: objective validation and sex differences in cigarette smokers. Presented to the 4th Annual meeting of the Society for Research on Nicotine and Tobacco, New Orleans, LA: March.
Johnson, R.E., Eissenberg, T., Strain, E.C., Walsh, S.L., and Bigelow, G.E. (1997). Dose comparison of LAAM during maintenance therapy. Presented to the 59th annual scientific meeting of the College on Problems of Drug Dependence, Nashville, TN, June, 1997.
Eissenberg, T., Stitzer, M.L., Bigelow, G.E., Buchhalter, A.R., and Walsh, S.L. (1997). LAAM is not less potent than methadone: a relative potency comparison of acute agonist effects. Presented to the 59th annual scientific meeting of the College on Problems of Drug Dependence, Nashville, TN, June, 1997.
Johnson, R.E., Eissenberg, T., Strain, E.C., Walsh, S.L., Brooner, R.K., Liebson, I.A., Stitzer, M.L., and Bigelow, G.E. (1996). LAAM dose comparison: a clinical trial. Presented to the 98th annual meeting of the American Society for Clinical Pharmacology and Therapeutics, San Diego, CA, March, 1997.
Eissenberg, T., Liebson, I.A., and Stitzer, M.L. (1996). Time course of naloxone-precipitated withdrawal after acute buprenorphine exposure in humans. Presented to the 58th annual scientific meeting of the College on Problems of Drug Dependence, San Juan, PR, June, 1996.
Stitzer, M.L., Eissenberg, T., Liebson, I.A., and Johnson, R.E. (1996). Relative potency of naltrexone and naloxone in precipitating withdrawal in humans. Presented to the 58th annual scientific meeting of the College on Problems of Drug Dependence, San Juan, PR, June, 1996.
Bigelow, G.E. Eissenberg, T., Stitzer, M.L., Walsh, S.L., Liebson, I.A., Strain, E.C., and Johnson, R.E. (1996). Less-than-daily buprenorphine dosing. Presented to the 58th annual scientific meeting of the College on Problems of Drug Dependence, San Juan, PR, June, 1996.
Johnson, R.E., Eissenberg, T., Strain, E.C., Walsh, S.L., Stitzer, M.L., Brooner, R.K., Liebson, I.A., and Bigelow, G.E. (1996). Rapid LAAM induction in an outpatient clinical trial. Presented to the 58th annual scientific meeting of the College on Problems of Drug Dependence, San Juan, PR, June, 1996.
Johnson, R.E., Eissenberg, T., Bigelow, G.E., Walsh, S.L., Liebson, I.A., Strain, E.C., and Stitzer, M.L. (1996). A pilot study of less-than-daily-dosing. Presented to the 97th annual meeting of the American Society for Clinical Pharmacology and Therapeutics, Lake Buena Vista, FL, March, 1996.
Eissenberg, T., Griffiths, R.R., Liebson, I.A., Lichtman, D., and Stitzer, M.L. (1995). Mecamylamine does not precipitate withdrawal in cigarette smokers. Paper presented to the 2nd annual meeting of the Society for Research on Nicotine and Tobacco, Washington, DC, March, 1996.
Eissenberg, T., Greenwald, M., Johnson, R.E., Liebson, I.A., Bigelow, G.E., and Stitzer, M.L. (1995). Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal. Poster presented to the 57th annual scientific meeting of the College on Problems of Drug Dependence, Scottsdale, AZ, June, 1995.
Johnson, R.E., Eissenberg, T., Alim, T.N., Vocci, F.J., Risher-Flowers, D.J., and Deutsch, S.I. (1995) Comparison of the withdrawal syndromes following abrupt termination of buprenorphine and methadone. Paper presented to the 57th annual scientific meeting of the College on Problems of Drug Dependence, Scottsdale, AZ, June, 1995.
Siegel, S., Allan, L.G., and Eissenberg, T. (1995). What does contingently elicit "contingent" color aftereffects? Paper presented to the First International Conference of the Australian Learning Group, Townsville, North Queensland, July 1995.
Allan, L.G., Siegel, S., Eissenberg, T., and Thomas, S.E. (1995). What elicits the Indirect ME? Paper presented to the Cognitive Science Association for Interdisciplinary Learning, Hood River, OR, July 1995.
Eissenberg, T., Allan, L.G., Siegel, S. and Petrov, N. Stimulus generalization and the indirect McCollough effect. Paper presented to the Psychonomic Society 34th Annual Meeting, Washington, D.C. November, 1993.
Eissenberg, T., Allan, L.G., Siegel, S, and Petrov, N. When do non-orthogonal grids elicit color aftereffects? Paper presented to the Canadian Society for Brain, Behaviour, and Cognitive Science 3rd Annual Meeting, Toronto, Ontario, Canada. July, 1993.
Eissenberg, T., Allan, L.G., and Siegel, S. How indirect is the "indirect" McCollough Effect? Paper presented to the Eastern Psychological Association 64th Annual Meeting, Arlington, VA, 1993.
Allan, L.G., Siegel, S. and Eissenberg, T. Contingency manipulations and the McCollough effect. Paper presented to the meeting of the Psychonomic Society, San Francisco, CA, 1991.
Eissenberg, T. An Evaluation of ERIC/TM's Review Process. Paper presented to the National Council on Measurement in Education, San Francisco, CA 1989.
| Assistant Professor, Virginia Commonwealth University,
Richmond, Virginia. Application of Statistics (PSYC 214), Spring, 1999 Special Topics: Grant-writing (PSYC 691), Fall 1998. Application of Statistics (PSYC 214), Spring, 1997. Drug Dependence (PMC 548), Guest lecturer Lecturer, Mount Allison University,
Sackville, New Brunswick, Canada. Lecturer, McMaster University, Hamilton, Ontario, Canada. |
Back to:
[Personal
Information] [Curriculum Vitae]
[Clinical Behavioral Pharmacology Lab Home] [Biopsychology
Home] [Psychology Home]